Product development seen in Clover result

By Dominique Patton

- Last updated on GMT

Australian health ingredients business Clover said sales of its
omega-3 oil and powders increased 21 per cent during the year on
higher demand from the supplement and infant nutrition sectors.

But progress in new products has been slow and new managing director Ian Brown says his attention will be fully focused on getting its soy products off the ground as well as establishing further opportunities for omega-3 in Europe and the US.

The company reported revenue of $A17.3 million for the year to end of June, with the majority coming from the sale of tuna oil to its 70 per cent-owned joint venture, Nu-Mega Ingredients.

It also sold some oil to other customers, and gained some revenue from other undisclosed sources.

Nu-Mega Ingredients supplies omega-3 oil and powder to customers across different sectors, with new customers during the year ranging from a Japanese confectionery business to makers of bars, cereals and canned goods in New Zealand and a bread firm in Indonesia.

Sales growth was however attributed to "continued advances in infant nutrition and the powdered supplement categories in Australia and New Zealand" , according to a statement issued on the Australian stock exchange.

Nu-Mega has signed a two-year global supply contract with an international infant formula company and says the deal will be a significant revenue boost.

But Clover is also looking for opportunities to reach the European and US markets, where media coverage of omega-3's benefits "has resulted in a more open response from food companies" .

It is also investing in research to improve on the microencapsulation of its fish oil to expand the applications for this product.

This will create the 'next generation' of its powdered Driphorm ingredients range, said Brown.

However the new managing director will be spending much of his time on the company's soy venture, which is developing a range of soy ingredients with a bland flavour for beverages, baked goods and frozen foods.

"Progress in this area has been slower than expected and one of my key focuses at the moment is to make sure these products are ready for the market," he told AP-Foodtechnology.com.

Clover said it is confident of concluding a supply agreement with a well-known Australian brand early in the coming year.

However the soy joint venture with Austgrains has resulted in start-up losses of $357,000.

R&D costs were also up significantly over the year, and combined with the impact of redundancy costs at Nu-Mega and the write-down of plant equipment, profits were down to A$453,000 from A$771,000 in the prior year.

Related news

Related products

Comprehensive Nutritional Lipid Solutions

Comprehensive Nutritional Lipid Solutions

Content provided by INNOBIO Corporation Limited | 24-Sep-2024 | White Paper

INNOBIO specializes in high-quality DurOmega® functional lipid products, emphasizing enhanced fatty acid quality and application performance.

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 08-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Nutritional Solutions for Women's Health

Nutritional Solutions for Women's Health

Content provided by INNOBIO Corporation Limited | 04-Oct-2023 | White Paper

INNOBIO provides innovative solutions for women to overcome a variety of health challenges throughout the life cycle, from emotional health, PMS management,...

Omega-3:Nutrition and Application Insight

Omega-3:Nutrition and Application Insight

Content provided by Cabio Biotech (Wuhan) Co., Ltd | 31-Jul-2023 | White Paper

Omega-3 long-chain polyunsaturated fatty acids (PUFAs) have numerous positive health benefits and are among the most extensively studied micronutrients....

Related suppliers

Follow us

Products

View more

Webinars